Klea Holding's Strategic Growth Amidst Challenging Conditions

Klea Holding has demonstrated resilience in the first half of 2026, achieving a revenue of €8.6 million despite regional instabilities. The company's strategy focused on maintaining profitability through adaptive cost structures, resulting in a positive EBITDA of €1.6 million and a net profit of €0.3 million.

Investment efforts include the establishment of Smart Health and the launch of Klea Pharmaceuticals, aimed at reinforcing its presence in the Middle East and Africa. Financially, Klea Holding reports a strong position with shareholders' equity of €27.9 million and a reduced financial debt of €3.9 million.

Despite cash outflows due to strategic expansions and debt management, Klea's net financial debt remains low. The company's focus on healthcare market opportunities in the region underpins its growth ambition, confirming its target of another profitable year in 2026.